Neuroimaging and neurocognitive abnormalities associated with bipolar disorder in old age
- PMID: 24006234
- PMCID: PMC3947373
- DOI: 10.1002/gps.4021
Neuroimaging and neurocognitive abnormalities associated with bipolar disorder in old age
Abstract
Objectives: Cognitive dysfunction is prevalent in older adults with bipolar disorder (BD). High white matter hyperintensity (WMH) burden, a marker of white matter disease, detected on T2/fluid-attenuated inversion recovery brain magnetic resonance imaging (MRI) has been consistently reported in BD across all age ranges, including older adults. Yet, whether high WMH burden is related to the excess cognitive impairment present in older adults with BD is unknown. Therefore, we examine whether higher WMH burden is related to worse cognitive function in older adults with BD.
Methods: This is a cross-sectional study of 27 non-demented BD patients aged ≥50 years and 12 similarly aged mentally healthy comparators (controls). Subjects underwent both brain MRI and comprehensive neurocognitive assessment. We employed correlational analyses to evaluate the burden of WMH and the relationship between WMH and cognitive function.
Results: Although BD subjects had worse performance in all cognitive domains, BD subjects had less total WMH burden (t[13.4] = -3.57, p = 0.003). In control subjects, higher WMH was related to lower global cognitive function (ρ = -0.57, n = 12, p = 0.05). However, WMH did not correlate with neuropsychological performance in BD subjects. Further, BD and control subjects did not differ with respect to total gray and hippocampal volumes.
Conclusions: Cognitive dysfunction in late-life BD does not appear to be due primarily to processes related to increased WMH or reduced gray matter volume. Future longitudinal studies should examine other potential neuroprogressive pathways such as inflammation, mitochondrial dysfunction, serum anticholinergic burden, and altered neurogenesis.
Keywords: aging; bipolar disorder; cognition; neuroimaging.
Copyright © 2013 John Wiley & Sons, Ltd.
Conflict of interest statement
Dr. Butters has received payment from the Northstar Neuroscience and Medtronic for providing NP assessment services to clinical trials and from Fox Learning Systems (via National Institutes of Health [NIH]-funded Small Business Innovation Research) for computerized test development. She is currently a consultant for GlaxoSmithKline, for whom she is interpreting the results of NP evaluations.
Dr. Gildengers has received research support from GlaxoSmithKline for an investigator-initiated study.
Dr. Mulsant has received research support in the form of pharmaceutical supplies for his NIH-sponsored research from Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, and Wyeth.
Dr. Reynolds has received research support in the form of pharmaceutical supplies for his NIH-sponsored research from Bristol-Myers Squibb, Eli Lilly and Company, Forest, and Pfizer,
All other authors report no financial relationships with commercial interests.
References
-
- Berk M, Kapczinski F, Andreazza AC, et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehavioral Rev. 2011;35:804–817. - PubMed
-
- Beyer JL, Kuchibhatla M, Payne ME, et al. Hippocampal volume measurement in older adults with bipolar disorder. Am J Geriatric Psychiatry: Off J Am Assoc Geriatric Psychiatry. 2004;12:613–620. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
